Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
Ilse MertensLuc F Van Gaal

Abstract

Plasminogen activator inhibitor type 1 (PAI-1), an inhibitor of fibrinolysis and an important and independent cardiovascular risk factor, has been shown to be elevated in obesity and type 2 diabetes. Recent study results have suggested that adipose tissue--visceral fat in particular--could play an important role in the fibrinolytic process.In order to assess the specific role of this fat distribution, we measured PAI-1 activity (AU/ml) and visceral fat (CT-scan at level L4-L5) in 2 groups of 30 overweight and obese diabetic and overweight and obese non-diabetic women. Subjects were matched for age, weight, body mass index, fat mass and total abdominal fat. Visceral adipose tissue and PAI-1 were significantly higher in diabetic women (p = 0.022 and p = 0.004 respectively) than in non-diabetic patients. Visceral fat correlated significantly with PAI-1 activity, even after correction for insulin and triglycerides (r = 0.28, p = 0.034). Stepwise regression analysis showed visceral fat as the most important determinant factor for PAI-1 in the whole group and in the non-diabetic group. In the diabetic group, fasting insulin was the most important determinant. These results show that visceral fat is more important than BMI or total bo...Continue Reading

Citations

Jul 20, 2010·Journal of Thrombosis and Thrombolysis·David KarasekDalibor Novotny
Dec 18, 2003·The American Journal of Medicine·James R Sowers
Jun 29, 2012·Thrombosis and Haemostasis·Mattias EkströmPer Tornvall
Mar 3, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroshi ImamuraKeishi Kubo
May 12, 2007·The Review of Diabetic Studies : RDS·Elzbieta KozekJacek Sieradzki
Sep 6, 2008·International Journal of Medical Sciences·Hidekuni Inadera
Oct 13, 2014·The American Journal of Cardiology·Denise L SmithBo Fernhall
May 13, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dalibor NovotnyLudek Slavik
Jul 16, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Christoph H SaelyHeinz Drexel
Apr 18, 2008·Thrombosis Research·David KarásekDalibor Novotný
Sep 19, 2007·Journal of Clinical Pharmacy and Therapeutics·S MarchesiE Mannarino
Jan 1, 2005·American Journal of Preventive Medicine·Kerry J StewartPamela Ouyang
Oct 27, 2004·Cardiology Clinics·James R Sowers
Nov 10, 2005·The Clinical Biochemist. Reviews·Gisela Wilcox
Feb 3, 2005·Obesity Research·Justo Sierra-JohnsonStephen T Turner
Jun 12, 2002·Circulation·Scott M Grundy
Dec 23, 2004·American Journal of Physiology. Endocrinology and Metabolism·Saori Miyazawa-HoshimotoYasushi Saito
Jan 29, 2005·Journal of Applied Physiology·Peter PlomgaardBente Klarlund Pedersen
Oct 9, 2007·Diabetes/metabolism Research and Reviews·Ilse MertensLuc F Van Gaal
Apr 12, 2005·AIDS·Daniel S Kamin, Steven K Grinspoon
May 4, 2021·Frontiers in Cardiovascular Medicine·Gael B MorrowNicola J Mutch

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Arteriosclerosis, Thrombosis, and Vascular Biology
M CigoliniG De Sandre
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
G S Hotamisligil
JAMA : the Journal of the American Medical Association
M VisserT B Harris
© 2021 Meta ULC. All rights reserved